Markels John 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Markels John
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-14+3,131→ 3,131 total - Award
Stock option (right to buy)
2024-06-14+15,000→ 15,000 totalExercise: $31.00Exp: 2034-06-14→ Common Stock (15,000 underlying) - Exercise/Conversion
Deferred Stock Units
2024-06-14−3,131→ 0 totalExercise: $0.00→ Common Stock (3,131 underlying)
Footnotes (3)
- [F1]Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024.
- [F2]Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
- [F3]Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.